|
Jun 2026
As of Jun 30, 2026
|
Mar 2026
As of Mar 31, 2026
|
|
|---|---|---|
| Assets | ||
| Non-controlled, non-affiliated investments (cost/amortized cost of $177,699,849 and $0, respectively) | ||
| Cash and cash equivalents | ||
| Deferred offering costs (net of expense sharing) (Notes 3 and 4) | ||
| Receivable from Adviser (Note 4) | ||
| Interest receivable | ||
| Total assets | ||
| Liabilities | ||
| Debt (net of deferred financing costs of $1,902,459 and $0, respectively) | ||
| Repurchase agreements | ||
| Organizational and offering costs payable | ||
| Professional and other fees payable | ||
| Trustees' fees payable (Note 4) | ||
| Deferred financing cost payable | ||
| Subscriptions received in advance | ||
| Payable for investments purchased | ||
| Investment income incentive fees payable | ||
| Capital gains incentive fees payable | ||
| Interest and other financing expenses payable | ||
| Management fee payable | ||
| Accrued expenses and other liabilities | ||
| Total liabilities | ||
| Net Assets | ||
| Common shares, $0.001 par value, unlimited common shares authorized; 2,520,578 and 1,000 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||
| Additional paid-in-capital | ||
| Total Net Assets | ||
| Total Liabilities and Net Assets | ||
| Net asset value per share |
Loading...
